Extract notice to the Minister

Mar-Afatinib

Common name / Subject : afatinib (dimaléate d')
Name of the manufacturer : Marcan
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription- Avec conditions

Minister's decisions
Inscrire aux listes des médicaments - Médicament d'exception

Evaluation published on April 10, 2025

Subscribe to our newsletter now

Subscription